SOMERSET, N.J. Catalent, the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene
The use of opioids for pain relief in patients awaiting hip and knee replacement surgery increased dramatically during the pandemic according to new research from
Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment